COVID-19 Vaccine Efficacy Affected by Hyperglycemia in Healthcare Workers

Strategic Insights -

Hyperglycemia may significantly impact the immune response to COVID-19 vaccines in healthcare workers, with individuals having diabetes or impaired fasting glucose showing lower spike IgG antibody titers. The study, led by the National Center for Global Health and Medicine in Tokyo, Japan, suggests that hyperglycemia can alter the activation of innate and acquired immunity, potentially affecting the effectiveness of COVID-19 vaccination. The research highlights the importance of considering glycemic status when evaluating vaccine efficacy and suggests that individuals with diabetes or impaired fasting glucose may require additional immunization strategies.

Key Takeaways:

  • The study involved 953 healthcare workers aged 21-75 years who received the BNT162b2 vaccine and had their SARS-CoV-2 spike IgG antibodies and fasting plasma glucose levels tested two months after the second dose.
  • Individuals with diabetes showed significantly lower spike IgG antibody titers compared to those with normoglycemia, with a ratio of means (95% CI) of 0.60 (0.42-0.87).
  • Impaired fasting glucose (IFG) was also associated with lower spike IgG antibody titers, with a ratio of means (95% CI) of 0.79 (0.60-1.04).
  • The study suggests that diabetes and, to a lesser extent, IFG may be associated with a poor humoral immune response after BNT162b2 vaccination.
  • The research emphasizes the need to consider glycemic status when evaluating vaccine efficacy and developing immunization strategies for individuals with diabetes or impaired fasting glucose.
  • The study involved a collaboration between researchers from the National Center for Global Health and Medicine, the Japan Health Research Promotion Bureau, and other institutions.

Statistics:

  • 953 healthcare workers were involved in the study, aged 21-75 years.
  • The study found that spike IgG antibody titers were lower in the presence of hyperglycemia, with a ratio of means (95% CI) of 0.60 (0.42-0.87) for individuals with diabetes.
  • Impaired fasting glucose was associated with a ratio of means (95% CI) of 0.79 (0.60-1.04) for spike IgG antibody titers.
  • The study was conducted in a tertiary hospital in Japan and involved health care workers who received the BNT162b2 vaccine.

Sources:

  • "Association of Impaired Fasting Glucose and Diabetes with SARS-CoV-2 Spike Antibody Titers after the BNT162b2 Vaccine among Health Care Workers in a Tertiary Hospital in Japan." Vaccines, 2022, 10(776):776. (Vaccines - http://www.mdpi.com/journal/vaccines).
  • National Center for Global Health and Medicine, Tokyo, Japan.